One of the vaccines that provides particularly good protection against COVID-19 is BNT162b2 from Mainz-based biotech company BioNTech. To scale-up the manufacturing capacity further,BioNTech had just acquired a new production facility from Novartis and needed to rapidly transform the plant into a COVID-19 vaccine facility.
Entire process flow controlled and
orchestrated using Siemens products:
Opcenter
Execution Pharma MES to
orchestrate subsystems and processes, and analyze their quality. Production
processes can be optimized and managed automatically
All systems were automated using the SIMATIC
PCS 7 process
control system.
Other products used include network
technology, WLAN access points, communication technology and the TIA Portal
engineering framework.
We want to thank Siemens for their excellent collaboration on this project and the huge effort they put in, often exceeding 100 percent.
Valeska Schilling, Head of Production Department, BioNTech Marburg
Project “Lightspeed” to repurpose a vaccines plant in 5 months.
Eliminate paper & integrate automated operations with an MES, delivered in 2.5 months
Rapid assemble a team of 22 engineers
Automatical optimization and management of processes
SIMATIC PCS 7 and TIA portal for control system and engineering framework enable improvements that are Industry 4.0-campatible
Precise measurement of weight for manual stages in mRNA processes ensuring high product quality
Project Engineering, implementation & hyper-care 24/7 by Siemens
